CMTM6 and glioma: Furthermore, CMTM6 expression was positively correlated with PD-L1 expression in various cancers including HNSCC (18), lung cancer (30, 69), gliomas (20), gastric cancer (33, 36), and colon cancer (40) (Table 1).